The pharmacokinetics of S-(-)equol administered as SE5-OH tablets to healthy postmenopausal women.
about
Equol: pharmacokinetics and biological actionsEquol: history, chemistry, and formationThe chemopreventive action of equol enantiomers in a chemically induced animal model of breast cancerThe role of colonic bacteria in the metabolism of the natural isoflavone daidzin to equolPharmaco- and toxicokinetics of selected exogenous and endogenous estrogens: a review of the data and identification of knowledge gaps.Flavonoids and age-related disease: risk, benefits and critical windows.Cautions and research needs identified at the equol, soy, and menopause research leadership conferenceEstrogen receptor and PI3K/Akt signaling pathway involvement in S-(-)equol-induced activation of Nrf2/ARE in endothelial cellsThe effects of dietary treatment with S-equol on learning and memory processes in middle-aged ovariectomized rats.Impact of perinatal exposure to equol enantiomers on reproductive development in rodents.Soy isoflavone phase II metabolism differs between rodents and humans: implications for the effect on breast cancer riskAcute benefits of the microbial-derived isoflavone metabolite equol on arterial stiffness in men prospectively recruited according to equol producer phenotype: a double-blind randomized controlled trial.S-(-)equol production is developmentally regulated and related to early diet compositionDietary factors influence production of the soy isoflavone metabolite s-(-)equol in healthy adultsPharmacokinetics of equol, a soy isoflavone metabolite, changes with the form of equol (dietary versus intestinal production) in ovariectomized ratsImpact of dietary soy isoflavones in pregnancy on fetal programming of endothelial function in offspring.Emerging evidence of the health benefits of S-equol, an estrogen receptor β agonist.Does equol production determine soy endocrine effects?Prenylated isoflavonoids from plants as selective estrogen receptor modulators (phytoSERMs).Soy isoflavones and glucose metabolism in menopausal women: A systematic review and meta-analysis of randomized controlled trials.Pharmacokinetics and safety profile of single-dose administration of an estrogen receptor β-selective phytoestrogenic (phytoSERM) formulation in perimenopausal and postmenopausal women.Bone Response to Dietary Co-Enrichment with Powdered Whole Grape and Probiotics.Use of isoflavone supplements is associated with reduced postmenopausal breast cancer risk
P2860
Q24594626-73C719C7-3D8E-4D22-AECA-2C57FF0EC455Q24594674-33383998-0F13-4498-B220-64A8492F1CAEQ24628910-2FE3FD78-7345-4955-A588-2FD7B17C8527Q28087603-0A9BA265-99C8-4247-9BC2-2F808632EDCAQ30841046-F262AE96-CA5A-41D0-8CF9-A6FCBCD768FCQ33889019-E9D70E44-DB31-474C-9147-175207E8D9D6Q33908755-4BC2113F-49A7-4E62-BEEA-0A5EA743D3FAQ35048199-5949FC63-B4A3-4F96-AE98-19FD7BDF2ACFQ35075992-323A2A68-37B5-4061-9FFA-D4DDCC5669D3Q35234941-F1BC65BE-C1B7-4232-AC2F-FF140F5B9D91Q35335557-C80C6186-E748-4341-A5BB-F906CA93369DQ35914108-0483848E-301B-4DFF-BB57-B39AE060AB3CQ37264845-F59C8591-385B-402D-86F3-C026C224B442Q37307326-7140E0A3-3E85-4B89-9570-C33E878FC937Q37697453-9D3E932E-5037-47EC-91ED-23914166557FQ37854853-B81A8D00-5445-47DE-849D-16BDC59C23EDQ37905857-D74D766C-3CFC-490D-B91D-F2148FB5164FQ37988309-AD150881-878B-4F8F-9109-6D0A82AE25D5Q38017574-2D3E49FA-71A4-4236-A8BD-ABD369A46C62Q38785296-E25E7A6A-E355-4DA3-9853-0E570BF59F57Q48106159-1907BDC9-4328-4B70-92AB-FDF652ECF64BQ49575546-BDFBEEBD-230A-4811-9DAA-097D54258CD7Q56672310-BF8E3B90-E389-41E5-BB16-5B47E254CF4B
P2860
The pharmacokinetics of S-(-)equol administered as SE5-OH tablets to healthy postmenopausal women.
description
2009 nî lūn-bûn
@nan
2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
The pharmacokinetics of S-(-)e ...... healthy postmenopausal women.
@ast
The pharmacokinetics of S-(-)e ...... healthy postmenopausal women.
@en
type
label
The pharmacokinetics of S-(-)e ...... healthy postmenopausal women.
@ast
The pharmacokinetics of S-(-)e ...... healthy postmenopausal women.
@en
prefLabel
The pharmacokinetics of S-(-)e ...... healthy postmenopausal women.
@ast
The pharmacokinetics of S-(-)e ...... healthy postmenopausal women.
@en
P2093
P356
P1433
P1476
The pharmacokinetics of S-(-)e ...... healthy postmenopausal women.
@en
P2093
Karen Ragland
Kenneth D R Setchell
Susan E Shoaf
Xueheng Zhao
P304
P356
10.3945/JN.109.110874
P407
P577
2009-09-23T00:00:00Z